Avalo Therapeutics (AVTX) EBIT (2014 - 2026)
Avalo Therapeutics' EBIT came in at -$31.52 million for Q2 2026, compared with -$19.32 million a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) EBIT (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Avalo Therapeutics reported EBIT of -$91.36 million; for FY2025, it came in at -$72.93 million.
- Going back by year, EBIT was -$68.51 million in FY2024, -$27.35 million in FY2023, -$37.44 million in FY2022 and -$82.13 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBIT since Q1 2024.
- Business Quant data shows AVTX's EBIT at -$20.9 million (Q1 2026), -$19.74 million (Q4 2025) and -$19.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - | -31.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.52 Mn |
| Mar 31, 2026 | -20.90 Mn |
| Dec 31, 2025 | -19.74 Mn |
| Sep 30, 2025 | -19.20 Mn |
| Jun 30, 2025 | -19.32 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Dec 31, 2024 | -13.31 Mn |
| Sep 30, 2024 | -12.86 Mn |
| Jun 30, 2024 | -9.58 Mn |
| Mar 31, 2024 | -32.77 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -3.75 Mn |
| Jun 30, 2023 | -7.15 Mn |
| Mar 31, 2023 | -8.79 Mn |
| Dec 31, 2022 | -8.86 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | -11.83 Mn |
| Mar 31, 2022 | -20.85 Mn |
| Dec 31, 2021 | -17.96 Mn |
| Sep 30, 2021 | -16.46 Mn |
API Access
Avalo Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();